Coherence for Health

Innovation for New Medicines for Infectious Diseases

image of Coherence for Health

In developing countries, 6 out of 10 people die from infectious diseases. Nearly 1 billion humans suffer from a neglected infectious disease, according to the World Health Organisation. Yet less than 1% of the new drugs placed on the market from 1975 to the turn of the century were developed for these diseases. This book looks at ways of improving the availability of medicines for infectious diseases through strengthened coherence in health, trade, science and technology, development co-operation and finance.



Present Policy Solutions Being Used to Address the Problems of Neglected Infectious Diseases

This chapter provides an overview of “push” and “pull” mechanisms being experimented with to bring new health technologies on to the market. Push mechanisms include both product development public-private partnerships and targeted R&D tax credits. Pull mechanisms include: advance market commitments; fast-track regulatory approval; patent extensions; pharmaceutical industry involvement; and financing mechanisms, such as the International Finance Facility, the currency transaction development levy, an airline tax, and the healthcare funding framework. Push and pull mechanisms are complementary models. Most commentators conclude that a combination of push, pull and PDP mechanisms is desirable and that the optimal mix may vary among different desired products and their stages of development.


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error